BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 37939900)

  • 1. Human Amniotic Membrane-Derived Mesenchymal Stem Cells Prevent Acute Graft-Versus-Host Disease in an Intestinal Microbiome-Dependent Manner.
    Bu X; Gao Y; Pan W; Liu L; Wang J; Yin Z; Ping B
    Transplant Cell Ther; 2024 Feb; 30(2):189.e1-189.e13. PubMed ID: 37939900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human Amniotic Mesenchymal Stem Cells Alleviate aGVHD after allo-HSCT by Regulating Interactions between Gut Microbiota and Intestinal Immunity.
    Bu X; Wang J; Yin Z; Pan W; Liu L; Jin H; Liu Q; Zheng L; Sun H; Gao Y; Ping B
    Stem Cell Rev Rep; 2023 Jul; 19(5):1370-1383. PubMed ID: 36870009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic Effects of HLA-G5 Overexpressing hAMSCs on aGVHD After Allo-HSCT: Involving in the Gut Microbiota at the Intestinal Barrier.
    Bu X; Pan W; Wang J; Liu L; Yin Z; Jin H; Liu Q; Zheng L; Sun H; Gao Y; Ping B
    J Inflamm Res; 2023; 16():3669-3685. PubMed ID: 37645691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human Amniotic Mesenchymal Stem Cells Inhibit aGVHD by Regulating Balance of Treg and T Effector Cells.
    Gao Y; Li W; Bu X; Xu Y; Cai S; Zhong J; Du M; Sun H; Huang L; He Y; Hu X; Liu Q; Jin H; Wang Q; Ping B
    J Inflamm Res; 2021; 14():3985-3999. PubMed ID: 34429630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intestinal Microbiota at Engraftment Influence Acute Graft-Versus-Host Disease
    Han L; Jin H; Zhou L; Zhang X; Fan Z; Dai M; Lin Q; Huang F; Xuan L; Zhang H; Liu Q
    Front Immunol; 2018; 9():669. PubMed ID: 29740427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tyrosine supplement ameliorates murine aGVHD by modulation of gut microbiome and metabolome.
    Li X; Lin Y; Li X; Xu X; Zhao Y; Xu L; Gao Y; Li Y; Tan Y; Qian P; Huang H
    EBioMedicine; 2020 Nov; 61():103048. PubMed ID: 33039712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human umbilical cord mesenchymal stem cells ameliorate colon inflammation via modulation of gut microbiota-SCFAs-immune axis.
    Liu A; Liang X; Wang W; Wang C; Song J; Guo J; Sun D; Wang D; Song M; Qian J; Zhang X
    Stem Cell Res Ther; 2023 Sep; 14(1):271. PubMed ID: 37749611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Potential Roles of Mucosa-Associated Invariant T Cells in the Pathogenesis of Gut Graft-Versus-Host Disease After Hematopoietic Stem Cell Transplantation.
    Gao MG; Hong Y; Zhao XY; Pan XA; Sun YQ; Kong J; Wang ZD; Wang FR; Wang JZ; Yan CH; Wang Y; Huang XJ; Zhao XS
    Front Immunol; 2021; 12():720354. PubMed ID: 34539656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracellular Vesicles Released from Human Umbilical Cord-Derived Mesenchymal Stromal Cells Prevent Life-Threatening Acute Graft-Versus-Host Disease in a Mouse Model of Allogeneic Hematopoietic Stem Cell Transplantation.
    Wang L; Gu Z; Zhao X; Yang N; Wang F; Deng A; Zhao S; Luo L; Wei H; Guan L; Gao Z; Li Y; Wang L; Liu D; Gao C
    Stem Cells Dev; 2016 Dec; 25(24):1874-1883. PubMed ID: 27649744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The combination of four main components in Xuebijing injection improved the preventive effects of Cyclosporin A in acute graft-versus-host disease mice by protecting intestinal microenvironment.
    Shang T; Guo Y; Li XR; Zhou Z; Qi Y; Salahdiin K; Shen R; He S; Wang M; Shi ZX; Zhao X; Yang J; Fan G; Wang Y; Gao X; Zhu Y; Feng Y
    Biomed Pharmacother; 2022 Apr; 148():112675. PubMed ID: 35183993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adipose tissue-derived human mesenchymal stromal cells can better suppress complement lysis, engraft and inhibit acute graft-versus-host disease in mice.
    Wu SCM; Zhu M; Chik SCC; Kwok M; Javed A; Law L; Chan S; Boheler KR; Liu YP; Chan GCF; Poon EN
    Stem Cell Res Ther; 2023 Jun; 14(1):167. PubMed ID: 37357314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exosomes Released From Human Bone Marrow-Derived Mesenchymal Stem Cell Attenuate Acute Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation in Mice.
    Li KL; Li JY; Xie GL; Ma XY
    Front Cell Dev Biol; 2021; 9():617589. PubMed ID: 33889570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut microbiota intervention by pre and probiotics can induce regulatory T cells and reduce the risk of severe acute GVHD following allogeneic hematopoietic stem cell transplantation.
    Yazdandoust E; Hajifathali A; Roshandel E; Zarif MN; Pourfathollah AA; Parkhideh S; Mehdizadeh M; Amini-Kafiabad S
    Transpl Immunol; 2023 Jun; 78():101836. PubMed ID: 37037266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intestinal Microbiota Can Predict Acute Graft-versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation.
    Han L; Zhang H; Chen S; Zhou L; Li Y; Zhao K; Huang F; Fan Z; Xuan L; Zhang X; Dai M; Lin Q; Jiang Z; Peng J; Jin H; Liu Q
    Biol Blood Marrow Transplant; 2019 Oct; 25(10):1944-1955. PubMed ID: 31299215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Research advances on short-chain fatty acids in gastrointestinal acute graft-
    Song X; Lao J; Wang L; Liu S
    Ther Adv Hematol; 2024; 15():20406207241237602. PubMed ID: 38558826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human mesenchymal stem cells suppress donor CD4(+) T cell proliferation and reduce pathology in a humanized mouse model of acute graft-versus-host disease.
    Tobin LM; Healy ME; English K; Mahon BP
    Clin Exp Immunol; 2013 May; 172(2):333-48. PubMed ID: 23574329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interplay Between the Intestinal Microbiota and Acute Graft-Versus-Host Disease: Experimental Evidence and Clinical Significance.
    Hong T; Wang R; Wang X; Yang S; Wang W; Gao Q; Zhang X
    Front Immunol; 2021; 12():644982. PubMed ID: 33815399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Umbilical cord blood-derived mesenchymal stromal cells promote myeloid-derived suppressor cell proliferation by secreting HLA-G to reduce acute graft-versus-host disease after hematopoietic stem cell transplantation.
    Yang S; Wei Y; Sun R; Lu W; Lv H; Xiao X; Cao Y; Jin X; Zhao M
    Cytotherapy; 2020 Dec; 22(12):718-733. PubMed ID: 32811747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced alleviation of aGVHD by TGF-β1-modified mesenchymal stem cells in mice through shifting MΦ into M2 phenotype and promoting the differentiation of Treg cells.
    Wu R; Liu C; Deng X; Chen L; Hao S; Ma L
    J Cell Mol Med; 2020 Jan; 24(2):1684-1699. PubMed ID: 31782262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human amniotic mesenchymal stem cells and their paracrine factors promote wound healing by inhibiting heat stress-induced skin cell apoptosis and enhancing their proliferation through activating PI3K/AKT signaling pathway.
    Li JY; Ren KK; Zhang WJ; Xiao L; Wu HY; Liu QY; Ding T; Zhang XC; Nie WJ; Ke Y; Deng KY; Liu QW; Xin HB
    Stem Cell Res Ther; 2019 Aug; 10(1):247. PubMed ID: 31399039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.